The association between metabolic abnormality and endometrial cancer: A large case-control study in China

Gynecologic Oncology

Volumn 117, Issue 1, 2010, Pages 41-46

  Zhang, Yan ^a   Liu, Zhiwei ^b   Yu, Xinchun ^c   Zhang, Xiaofei ^d   Lü, Shiming ^a   Chen, Xiaoduan ^d   Lü, Bingjian ^d  

^a First Affiliated Hospital   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c Quzhou People's Hospital   (China)

^d ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Diabetes mellitus; Endometrial cancer; Metabolic syndrome; Obesity; Serum lipid

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; BODY MASS; CALCULATION; CANCER GROWTH; CANCER RISK; CASE CONTROL STUDY; CHINA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENDOMETRIUM CANCER; FEMALE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MENOPAUSE; METABOLIC DISORDER; OBESITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

BODY MASS INDEX; CASE-CONTROL STUDIES; CHINA; DIABETES MELLITUS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYPERTENSION; MENOPAUSE; METABOLIC SYNDROME X; NEOPLASM STAGING; RISK FACTORS;

EID: 77949299792     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.12.029     Document Type: Article

References (45)

1. DeFronzo R.A., and Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14 (1991) 173-194
2. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
3. Calle E.E., and Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4 (2004) 579-591
4. Renehan A.G., Tyson M., Egger M., Heller R.F., and Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371 (2008) 569-578
5. Seow A., Yuan J.M., Koh W.P., Lee H.P., and Yu M.C. Diabetes mellitus and risk of colorectal cancer in the Singapore Chinese Health Study. J. Natl. Cancer Inst. 98 (2006) 135-138
6. Furberg A.S., Veierød M.B., Wilsgaard T., Bernstein L., and Thune I. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J. Natl. Cancer Inst. 96 (2004) 1152-1160
7. Patel A.V., Feigelson H.S., Talbot J.T., McCullough M.L., Rodriguez C., Patel R.C., et al. The role of body weight in the relationship between physical activity and endometrial cancer: results from a large cohort of US women. Int. J. Cancer 123 (2008) 1877-1882
8. Bjørge T., Engeland A., Tretli S., and Weiderpass E. Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int. J. Cancer 120 (2006) 378-383
9. Schouten L.J., Goldbohm R.A., and van den Brandt P.A. Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study. J. Natl. Cancer Inst. 96 (2004) 1635-1638
10. Shoff S.M., and Newcomb P.A. Diabetes, body size, and risk of endometrial cancer. Am. J. Epidemiol. 148 (1998) 234-240
11. Cust A.E., Kaaks R., Friedenreich C., Bonnet F., Laville M., Tjønneland A., et al. Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr. Relat. Cancer 14 (2007) 755-767
12. Wideroff L., Gridley G., Mellemkjaer L., Chow W.H., Linet M., Keehn S., et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J. Natl. Cancer Inst. 89 (1997) 1360-1365
13. Hecht J.L., and Mutter G.L. Molecular and pathologic aspects of endometrial carcinogenesis. J. Clin. Oncol. 24 (2006) 4783-4791
14. Forney J.P., Milewich L., Chen G.T., Garlock J.L., Schwarz B.E., Edman C.D., et al. Aromatization of androstenedione to estrone by human adipose tissue in vitro. Correlation with adipose tissue mass, age, and endometrial neoplasia. J. Clin. Endocrinol. Metab. 53 (1981) 192-199
15. Gu D., Reynolds K., Wu X., Chen J., Duan X., Reynolds R.F., et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365 (2005) 1398-1405
16. Ministry of Health, PRC. The status of health and nutrition in Chinese. In The 2007 annual statistics of health in China (2007), Peking Union Medical College Press, Peking 216 (In Chinese)
17. Huang Y., Huang W., Long S., Li L., Tang B., and Yang B. Analysis of 1466 endometrial carcinomas in inpatients in Guangxi Zhuang Autonomous region: a 20 years' analysis. Acad. J. Sec. Mil. Med. Univ. 681-4 In Chinese (2007) 28
18. Luo W., Morrison H., de Groh M., Waters C., DesMeules M., Jones-McLean E., et al. The burden of adult obesity in Canada. Chronic Dis. Can. 27 (2007) 135-144
19. Xu W., Matthews C.E., Xiang Y., Zheng W., Ruan Z., Chen J., et al. Effect of adiposity and fat distribution on endometrial cancer risk in Shanghai women. Am. J. Epidemiol. 161 (2005) 939-947
20. de Onis M., and Habicht J.P. Anthropometric reference data for international use: recommendations from a World Health Organization Expert Committee. Am. J. Clin. Nutr. 64 (1996) 650-658
21. National Cholesterol Education Program (NCEP) Expert Panel on Detection. Evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
22. National Measures Dyslipidemia Control Group. Prevention and treatment recommendations for dyslipidemia. Chin. J. Cardiovasc. Dis. 25 (1997) 169-175 (In Chinese)
23. Mazur M.T., and Kurman R.J. Endometrial carcinoma. In: Mazur M.T., and Kurman R.J. (Eds). Diagnosis of Endometrial Biopsies and Currentings. Edn 2 (2003), Springer Science+Business Media, Inc., New York 208-248
24. Lucenteforte E., Talamini R., Montella M., Dal Maso L., Pelucchi C., Franceschi S., et al. Family history of cancer and the risk of endometrial cancer. Eur. J. Cancer Prev. 18 (2009) 95-99
25. McCullough M.L., Patel A.V., Patel R., Rodriguez C., Feigelson H.S., Bandera E.V., et al. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. Cancer Epidemiol. Biomarkers Prev. 17 (2008) 73-79
26. Weiderpass E., Persson I., Adami H.O., Magnusson C., Lindgren A., and Baron J.A. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 11 (2000) 185-192
27. Kaaks R., Lukanova A., and Kurzer M.S. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol. Biomarkers Prev. 11 (2002) 1531-1543
28. Potischman N., Hoover R.N., Brinton L.A., Siiteri P., Dorgan J.F., Swanson C.A., et al. Case-control study of endogenous steroid hormones and endometrial cancer. J. Natl. Cancer Inst. 88 (1996) 1127-1135
29. Furberg A.S., and Thune I. Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort. Int. J. Cancer 104 (2003) 669-676
30. Friedenreich C., Cust A., Lahmann P.H., Steindorf K., Boutron-Ruault M.C., Clavel-Chapelon F., et al. Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Cancer Causes Control 18 (2007) 399-413
31. La Vecchia C., Parazzini F., Negri E., Fasoli M., Gentile A., and Franceschi S. Anthropometric indicators of endometrial cancer risk. Eur. J. Cancer 27 (1991) 487-490
32. Lukanova A., Zeleniuch-Jacquotte A., Lundin E., Micheli A., Arslan A.A., Rinaldi S., et al. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. Int. J. Cancer 108 (2004) 262-268
33. Saltzman B.S., Doherty J.A., Hill D.A., Beresford S.A., Voigt L.F., Chen C., et al. Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors. Am. J. Epidemiol. 167 (2008) 607-614
34. Lucenteforte E., Bosetti C., Talamini R., Montella M., Zucchetto A., Pelucchi C., et al. Diabetes and endometrial cancer: effect modification by body weight, physical activity and hypertension. Br. J. Cancer 97 (2007) 995-998
35. Salazar-Martínez E., Lazcano-Ponce E.C., Lira-Lira G.G., Escudero-De los Rios P., Salmerón-Castro J., Larrea F., et al. Case-control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women. Cancer Causes Control 11 (2000) 707-711
36. Anderson K.E., Anderson E., Mink P.J., Hong C.P., Kushi L.H., Sellers T.A., et al. Diabetes and endometrial cancer in the Iowa women's health study. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 611-616
37. Currie C.J., Poole C.D., and Gale E.A. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 52 (2009) 1766-1777
38. Lewis JD, Capra AM, Achacoso NS, Ferrara A, Levin TR, Quesenberry CP Jr, et al. Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus. Gastroenterology 2008;135:1914-23, 1923.e1.
39. Bergström A., Pisani P., Tenet V., Wolk A., and Adami H.O. Overweight as an avoidable cause of cancer in Europe. Int. J. Cancer 91 (2001) 421-430
40. Saxena N.K., Taliaferro-Smith L., Knight B.B., Merlin D., Anania F.A., O'Regan R.M., et al. Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor. Cancer Res. 68 (2008) 9712-9722
41. Augustin L.S., Gallus S., Bosetti C., Levi F., Negri E., Franceschi S., et al. Glycemic index and glycemic load in endometrial cancer. Int. J. Cancer 105 (2003) 404-407
42. Bandera E.V., Kushi L.H., Moore D.F., Gifkins D.M., and McCullough M.L. Dietary lipids and endometrial cancer: the current epidemiologic evidence. Cancer Causes Control 18 (2007) 687-703
43. Lindemann K., Vatten L.J., Ellstrøm-Engh M., and Eskild A. Serum lipids and endometrial cancer risk: results from the HUNT-II study. Int. J. Cancer 124 (2009) 2938-2941
44. Swanson C.A., Potischman N., Barrett R.J., Berman M.L., Mortel R., Twiggs L.B., et al. Endometrial cancer risk in relation to serum lipids and lipoprotein levels. Cancer Epidemiol. Biomarkers Prev. 3 (1994) 575-581
45. Park S.L., Goodman M.T., Zhang Z.F., Kolonel L.N., Henderson B.E., and Setiawan V.W. Body size, adult BMI gain and endometrial cancer risk: The Multiethnic Cohort. Int. J. Cancer 1260 (2010) 490-499